Welcome to the CJU website » LOG IN


Prostatic inflammation in benign prostatic hyperplasia - the third component?
Associate Professor, Department of Urology, Queen's University and Staff Ur
Jan  1994 (Vol.  1, Issue  1, Pages( 1 - 4)


Text-Size + 

  • The etiology, diagnosis, therapy and treatment outcome of the two most common nonmalignant disease of the prostate remain problematic. Benign prostatic hyperplasia and prostatic inflammation can coexist yet these conditions have been studied in almost complete isolation. The author develops the hypothesis that prostatic inflammation (prostatitis) can influence the clinical presentation and perhaps surgical outcome in patients treated for symptomatic benign prostatic hyperplasia.

Current Issue

October 2021, Vol.28 No.5
canadian journal of urology